Tandem Diabetes Care (NASDAQ: TNDM) reported Q3 EPS of ($0.85), $0.03 worse than the analyst estimate of ($0.82). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $13.6 million.

For earnings history and earnings-related data on Tandem Diabetes Care (TNDM) click here.